Data / Drug companies / PD-Rx Pharmaceuticals, Inc.
PD-Rx Pharmaceuticals, Inc.: 60 products in the FDA NDC directory, labeler code 55289
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
PD-Rx Pharmaceuticals, Inc. (labeler code 55289) lists 60 products in the FDA National Drug Code Directory, covering 50 finished drugs by generic name. By type: 52 prescription drugs, 8 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on March 27, 2021.
The request: Watch PD-Rx Pharmaceuticals, Inc. (FDA labeler code 55289): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 55289
- Products in commercial distribution
- 60
- Packages
- 260
- Finished drugs by generic name
- 50
- Prescription products
- 52
- Over the counter products
- 8
- Controlled substance products
- Schedule IV 7
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 1
- Earliest marketing start
- June 3, 1975
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 54 | 90% |
| Over the counter monograph drugs | 6 | 10% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 52 | 86.7% |
| Over the counter drugs | 8 | 13.3% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 27 | 45% |
| Capsule | 15 | 25% |
| Tablet, film coated | 10 | 16.7% |
| Suppository | 2 | 3.3% |
| Tablet, film coated, extended release | 2 | 3.3% |
| Tablet, delayed release | 1 | 1.7% |
| Tablet, coated | 1 | 1.7% |
| Capsule, extended release | 1 | 1.7% |
| Tablet, chewable | 1 | 1.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Fiber Lax | 55289-949 | Tablet, film coated | Over the counter monograph drugs | March 27, 2021 |
| Loratadine Allergy Relief | 55289-728 | Tablet | Generic drugs (ANDA) | November 1, 2017 |
| Docusate Sodium | 55289-493 | Capsule | Over the counter monograph drugs | March 1, 2016 |
| Diphenhydramine HCl | 55289-479 | Capsule | Over the counter monograph drugs | February 1, 2016 |
| Phentermine Hydrochloride | 55289-701 | Tablet | Generic drugs (ANDA) | August 15, 2012 |
| Phentermine Hydrochloride | 55289-791 | Capsule | Generic drugs (ANDA) | August 7, 2012 |
| Phentermine Hydrochloride | 55289-624 | Capsule | Generic drugs (ANDA) | August 7, 2012 |
| Erythromycin | 55289-075 | Tablet, film coated | Generic drugs (ANDA) | September 6, 2011 |
| Chlorzoxazone | 55289-633 | Tablet | Generic drugs (ANDA) | August 22, 2011 |
| Verapamil hydrochloride | 55289-723 | Tablet, film coated, extended release | Generic drugs (ANDA) | September 17, 2009 |
| Indomethacin | 55289-469 | Capsule, extended release | Generic drugs (ANDA) | March 6, 2009 |
| Paroxetine | 55289-053 | Tablet, film coated | Generic drugs (ANDA) | March 24, 2008 |
| Paroxetine | 55289-037 | Tablet, film coated | Generic drugs (ANDA) | March 24, 2008 |
| Cetirizine Hydrochloride | 55289-995 | Tablet | Generic drugs (ANDA) | December 27, 2007 |
| Lovastatin | 55289-692 | Tablet | Generic drugs (ANDA) | November 1, 2007 |
| Famciclovir | 55289-168 | Tablet, film coated | Generic drugs (ANDA) | September 5, 2007 |
| Paroxetine | 55289-972 | Tablet, film coated | Generic drugs (ANDA) | April 13, 2007 |
| Meloxicam | 55289-272 | Tablet | Generic drugs (ANDA) | March 7, 2007 |
| Acetaminophen Regular strength | 55289-563 | Tablet | Over the counter monograph drugs | January 9, 2007 |
| Gabapentin | 55289-959 | Tablet | Generic drugs (ANDA) | April 1, 2006 |
| Fluconazole | 55289-824 | Tablet | Generic drugs (ANDA) | January 25, 2006 |
| Lisinopril | 55289-884 | Tablet | Generic drugs (ANDA) | January 13, 2006 |
| Acetaminophen | 55289-880 | Tablet | Over the counter monograph drugs | January 10, 2006 |
| Nifedipine | 55289-798 | Tablet, film coated, extended release | Generic drugs (ANDA) | November 21, 2005 |
| Metoprolol Tartrate | 55289-382 | Tablet, film coated | Generic drugs (ANDA) | February 23, 2004 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.